By Emily Olsen
Published May 15, 2026
In a strategic maneuver signaling its deepening commitment to the healthcare technology sector, Oracle has appointed Dr. Tomislav Mihaljevic, the CEO and President of the Cleveland Clinic, to its board of directors. The appointment, announced this week, marks a significant infusion of clinical leadership into the tech giant’s governance as it navigates the complex, often turbulent transition from traditional enterprise software to a dominant force in the electronic health record (EHR) and clinical AI marketplace.
Dr. Mihaljevic’s arrival follows the appointment of former Quest Diagnostics CEO Stephen Rusckowski, reinforcing Oracle’s ongoing efforts to align its board with the specific regulatory, operational, and clinical demands of the healthcare industry.
Main Facts: A New Era for Oracle Health
The decision to bring Dr. Mihaljevic into the fold is not merely a personnel change; it is a declaration of intent. With more than two decades of experience within the Cleveland Clinic—one of the most prestigious healthcare systems in the world—Mihaljevic brings a practitioner’s perspective to a board historically dominated by technology and enterprise software veterans.
Mihaljevic joined the Cleveland Clinic in 2004, initially serving in the department of thoracic and cardiovascular surgery. His ascent to the top of the organization was marked by a stint as the CEO of Cleveland Clinic Abu Dhabi, a role that required him to oversee complex international medical operations and infrastructure integration. His previous board experience with GE HealthCare further cements his profile as a leader who understands the intersection of medical devices, data systems, and hospital management.
By expanding its board to 13 members, Oracle is clearly looking to bridge the "language gap" between Silicon Valley developers and frontline clinicians—a gap that many analysts believe has hindered the adoption of the company’s post-Cerner software offerings.
Chronology: From Cerner Acquisition to AI Integration
To understand the significance of this appointment, one must look at the timeline of Oracle’s aggressive expansion into the healthcare vertical:
- June 2022: Oracle officially closes its $28.3 billion acquisition of Cerner, the massive EHR provider. This move was framed by Oracle leadership as the "largest growth engine" for the company’s future.
- Early 2025: Oracle launches a next-generation EHR platform powered by artificial intelligence, designed to address the "click fatigue" that has plagued modern digital health records for years.
- Mid-2025: Reports from Klas Research indicate that despite the new releases, Oracle Health faces significant headwinds, including stagnant customer satisfaction levels and the loss of several key hospital accounts.
- Late 2025: Oracle introduces a suite of AI-driven clinical assistants and automated patient portal tools aimed at reducing administrative burden.
- May 2026: Dr. Tomislav Mihaljevic joins the Oracle Board of Directors, signaling a pivot toward clinician-led design and long-term retention strategies.
Supporting Data: The Competitive Landscape
Oracle’s push into healthcare is occurring in a highly competitive and saturated market. According to recent industry analysis, the company remains in a challenging race against Epic, which holds the majority share of the acute care hospital market.
The Klas Research report from last summer highlighted the "post-acquisition blues" that often affect large-scale EHR migrations. As hospitals faced uncertainty during the integration of Cerner into the Oracle ecosystem, some providers began to look elsewhere. The data showed that customer satisfaction, which was already sensitive in the EHR market, had plateaued during the transition.
However, the technology Oracle is now deploying is ambitious. The new AI-backed EHR allows for voice-command navigation, a feature specifically designed to keep doctors’ eyes on patients rather than screens. Furthermore, the company’s "Clinical Digital Assistant" is designed to transcribe patient interactions in real-time and automate the mundane documentation tasks that lead to provider burnout—a critical metric in modern hospital management.
Official Responses and Strategic Rationale
The appointment has been met with optimism from Oracle’s executive suite. Clay Magouyrk, Executive Vice President of Oracle Cloud Infrastructure, emphasized the necessity of having a voice like Mihaljevic’s in the boardroom.
"Tom’s perspective will be invaluable as Oracle continues to help healthcare organizations use technology to improve outcomes for patients and providers," Magouyrk stated. "His experience running one of the most sophisticated health systems globally gives him a unique vantage point on where current technology fails and where it can truly innovate."
Industry observers suggest that for Oracle, the appointment serves as a "stamp of legitimacy." By having a sitting CEO of a globally recognized health system on its board, Oracle can better market its solutions not just as software, but as clinically validated systems that understand the daily workflow of a surgeon or a nurse.
Implications: What This Means for the Future of Healthcare
The implications of this appointment are threefold:
1. Refocusing on Clinical Workflow
For years, EHRs have been criticized for prioritizing billing and data collection over patient care. By bringing in Mihaljevic, Oracle is signaling that its future software development will be dictated by clinical utility. If Oracle can prove that its software reduces the time clinicians spend in the EHR, it could stem the tide of customer attrition and begin to win back market share from Epic.
2. Deepening AI Integration
The future of Oracle’s healthcare strategy lies in "ambient intelligence"—the ability of computers to listen, record, and suggest treatments without active input. Mihaljevic’s expertise will be crucial in ensuring that these AI tools remain ethical, accurate, and compliant with the stringent safety requirements of clinical practice.
3. A Shift in Governance
The transition from a pure tech board to a hybrid board is a trend across the industry. As technology becomes the bedrock of hospital operations, the "tech-only" approach is no longer sufficient. Oracle’s move likely sets a precedent for other cloud giants, such as Amazon (via AWS Health) and Microsoft (via Nuance), who are also vying for a piece of the healthcare data pie.
4. Addressing Customer Satisfaction
The primary challenge for Oracle in 2026 and beyond is retention. The loss of customers cited by Klas Research is a warning that Oracle cannot afford to ignore. Mihaljevic will likely be tasked with advising the company on how to improve the "human" side of their tech implementations—focusing on customer service, user experience, and the cultural transition required when a hospital switches its digital backbone.
Conclusion
Dr. Mihaljevic’s appointment is a calculated bet. By embedding one of the world’s most respected healthcare leaders into its governing body, Oracle is attempting to reposition itself as a partner to the medical community rather than just a vendor of software. Whether this change in leadership results in a tangible improvement in clinical outcomes and market retention remains to be seen. However, it is clear that Oracle is committed to the long-term, high-stakes endeavor of digitizing the global healthcare system, and it is prepared to change its internal culture to get there.
